This trial is testing whether adding 30 minutes of exercise before each immunotherapy treatment can improve outcomes.
4 Primary · 0 Secondary · Reporting Duration: Up to 12 months
Active Control
Experimental Treatment
32 Total Participants · 4 Treatment Groups
Primary Treatment: Checkpoint Blockade, Immune · No Placebo Group · Phase < 1
Age 18+ · All Participants · 10 Total Inclusion Criteria
Mark “Yes” if the following statements are true for you: